Global Gout Therapeutics Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Gout Therapeutics Market In The Coming Years?
In recent years, the market size of gout therapeutics has seen swift expansion. The market is projected to escalate from $2.88 billion in 2024 to $3.22 billion in 2025, marking a compound annual growth rate (CAGR) of 11.9%. The notable growth in the historical period is due to factors such as the rising incidents of gout, changes in lifestyle and diet habits, increased instances of high blood pressure and diabetes, the progression of xanthine oxidase inhibitors, and initiatives for patient education.
The market size for gout therapeutics is anticipated to witness robust expansion in the coming years. The market is projected to reach a valuation of $5 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.7%. The surge in growth during the forecast period can be ascribed to the increase in healthcare spending, breakthroughs in drug delivery systems, development of new therapies, government efforts to control chronic diseases, and the promotion of patient advocacy and support associations. Upcoming trends during the forecast period encompass innovation in drug development, approval of revolutionary drugs, approaches towards personalized medicines, adoption of telehealth services for gout management, and research in therapies lowering urate levels.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp
Which Growth Drivers Are Shaping The Gout Therapeutics Market Outlook?
The escalation in gout incidents is predicted to fuel the expansion of the gout therapeutics market. Gout is an inflammatory arthritis condition that triggers pain and swelling in the joints. Therapeutics for this condition work to alleviate the discomfort, swelling, and tenderness in the joints. Therefore, the sales in the gout therapeutics market are anticipated to be bolstered by the increasing prevalence of gout. For example, in June 2024, it was reported by the US-based government agency, The Australian Institute of Health and Welfare that gout was the underlying cause in 573 fatalities in Australia in 2022, which translates to 2.2 deaths for every 100,000 individuals. Hence, the gout therapeutics market’s growth is being stimulated by the rising frequency of gout.
What Is The Segment Breakdown Of The Gout Therapeutics Market?
The gout therapeuticsmarket covered in this report is segmented –
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroid; Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor; Uricosuria Medication
3) By Disease Condition: Acute; Chronic
4) By End-Users: Hospitals; Specialty Clinics; Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids; Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics; Loop Diuretics
What New Opportunities Are Emerging From Trends In The Gout Therapeutics Market?
The main trend emerging in the gout therapeutics market is product innovation. Major players in the market are developing novel treatments to maintain their market position. For example, Synlogic Inc., a pharmaceutical company based in the US, introduced SYNB2081, a new drug candidate for treating gout in August 2022. This drug is a synthetic biotic designed to decrease uric acid levels, representing the second clinical drug produced as a result of the research partnership between Synlogic and Ginkgo, a biotech firm situated in the US.
Who Are The Major Stakeholders Operating In The Gout Therapeutics Market?
Major companies operating in the gout therapeutics market include Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Gout Therapeutics Market?
North America was the largest region in the gout therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12118&type=smp
Browse Through More Reports Similar to the Global Gout Therapeutics Market 2025, By The Business Research Company
Electricity And Signal Testing Instruments Global Market Report 2025
Non Animal Alternatives Testing Global Market Report 2025
Pharmaceutical Sterility Testings Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
